IRIS UniCatt

Fianchi, Luana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.657
NA - Nord America 4.138
AS - Asia 1.771
SA - Sud America 211
AF - Africa 38
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.836
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.100
DE - Germania 1.995
SE - Svezia 795
CN - Cina 774
SG - Singapore 575
UA - Ucraina 357
IT - Italia 337
PL - Polonia 253
FR - Francia 221
IE - Irlanda 195
BR - Brasile 175
GB - Regno Unito 156
IN - India 136
ID - Indonesia 119
FI - Finlandia 100
RU - Federazione Russa 99
TR - Turchia 38
JP - Giappone 30
NL - Olanda 26
BE - Belgio 21
HK - Hong Kong 21
AT - Austria 19
CA - Canada 17
ES - Italia 16
CI - Costa d'Avorio 15
MX - Messico 15
AU - Australia 13
KR - Corea 11
AR - Argentina 9
CZ - Repubblica Ceca 9
IR - Iran 9
RO - Romania 9
VN - Vietnam 9
LT - Lituania 8
ZA - Sudafrica 8
CL - Cile 7
GR - Grecia 7
IQ - Iraq 7
NO - Norvegia 7
CO - Colombia 6
EC - Ecuador 6
TH - Thailandia 6
BG - Bulgaria 5
IL - Israele 5
LV - Lettonia 5
EG - Egitto 4
HU - Ungheria 4
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
PK - Pakistan 4
BD - Bangladesh 3
CH - Svizzera 3
MA - Marocco 3
PA - Panama 3
AZ - Azerbaigian 2
BW - Botswana 2
DO - Repubblica Dominicana 2
EU - Europa 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 10.836
Salva come PNG Salva come JPEG
Città #
Chandler 811
Singapore 345
Ashburn 283
Jacksonville 260
Warsaw 248
San Mateo 184
Dublin 183
Ann Arbor 172
Dearborn 159
Nanjing 155
Wilmington 141
Houston 120
Nürnberg 120
Jakarta 117
Woodbridge 108
New York 107
Beijing 89
Milan 83
Fairfield 80
Boston 76
Bremen 75
Moscow 72
Seattle 67
Lawrence 66
Munich 65
Cattolica 63
Nanchang 53
Redwood City 50
Los Angeles 49
Zhengzhou 46
Redmond 45
Hyderabad 41
Marseille 41
Shenyang 38
Princeton 37
Kunming 36
Shanghai 36
Hangzhou 35
Rome 35
Lancaster 32
Leawood 30
Cambridge 29
Frankfurt am Main 29
Chicago 28
Hebei 26
Auburn Hills 25
Izmir 24
Boardman 23
Brussels 21
Jiaxing 21
Mountain View 21
Tianjin 21
São Paulo 20
Augusta 19
Hefei 19
Hong Kong 19
Norwalk 19
Falls Church 18
Guangzhou 18
University Park 18
Düsseldorf 17
Nuremberg 17
Changsha 16
Chatsworth 16
Pune 16
Abidjan 15
Philadelphia 15
Jinan 13
London 13
The Dalles 13
Helsinki 12
Fremont 11
Lauterbourg 10
Simi Valley 10
Tokyo 10
Toronto 8
Costa Mesa 7
Edinburgh 7
Lanzhou 7
Lappeenranta 7
Monmouth Junction 7
Portsmouth 7
San Diego 7
San Francisco 7
Vienna 7
Washington 7
Enterprise 6
Hanoi 6
Kansas City 6
Ningbo 6
Rio de Janeiro 6
San Jose 6
Seoul 6
Taizhou 6
Amsterdam 5
Andover 5
Bari 5
Barletta 5
Chengdu 5
Falkenstein 5
Totale 5.631
Salva come PNG Salva come JPEG
Nome #
Incidence of acute myeloid leukemia after breast cancer 338
Factors associated with mortality in bacteremic patients with hematologic malignancies. 310
Factors associated with mortality in bacteremic patients with haematologic malignancies 307
Fanconi anemia gene variants in therapy-related myeloid neoplasms 272
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 214
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 188
Factors associated with mortality in bacteremic patients with hematologic malignancies. 176
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 176
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 168
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 162
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 152
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 148
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 145
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 141
Why methylation is not a marker predictive of response to hypomethylating agents 141
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 140
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 137
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 135
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 134
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 131
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 131
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 126
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 125
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 124
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 123
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 118
Primary plasma cell leukemia followed by testicular plasmacytoma 117
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 115
Epigenetic changes in therapy-related MDS/AML 114
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 114
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 113
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 113
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 113
Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency 112
Similarities and differences between therapy-related and elderly acute myeloid leukemia 111
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 110
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 107
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 106
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 103
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 103
Outcome of therapy-related myeloid neoplasms treated with azacitidine 98
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 98
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 97
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 97
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 96
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 96
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 94
Clonal evolution in therapy-related neoplasms 93
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 92
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 91
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 91
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 90
Small lymphocytic lymphoma in a patient with Fabry disease 89
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 89
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 86
Small lymphocytic lymphoma in a patient with Fabry disease 84
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 84
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 83
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 82
Newly proposed therapy-related myelodysplastic syndrome prognostic score predicts significant differences in overall survival and leukemia-free survival in patients treated with azacitidine 82
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 81
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 81
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia 77
High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study 74
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 74
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 73
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 72
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 72
Therapy-related myeloid neoplasms 72
Therapy-related myeloid neoplasms: Clinical perspectives 72
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 71
Current therapeutic approaches to fungal infections in immunocompromised hematological patients 70
Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia 70
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath? 69
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up: The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 66
Rapid response of nodular CD30-positive mycosis fungoides to brentuximab vedotin 65
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 64
Allogeneic Transplant for Mycosis Fungoides in Patient with Wiskott-Aldrich Syndrome 64
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 64
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study 63
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 62
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 62
Dose-dependent effect of granulocyte transfusions in hematological patients with febrile neutropenia 61
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 61
The role of neutrophils in the development and outcome of zygomycosis in haematological patients 60
Polymorphisms within the ARNT2 and CX3CR1 Genes Are Associated with the Risk of Developing Invasive Aspergillosis 60
. Pulmonary aspergillosis: lights and shadows 59
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis 58
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 58
Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium 56
ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies. 53
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) 52
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient 52
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 52
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 51
Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics Consortium 51
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality? 51
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study) 51
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry 51
Breakthrough zygomycosis and voriconazole 46
Totale 10.346
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020223 0 0 0 0 0 0 0 0 0 0 117 106
2020/20211.089 40 93 24 88 136 118 133 29 105 58 231 34
2021/20221.028 108 69 12 43 75 49 26 164 55 85 141 201
2022/20232.152 270 303 185 382 151 255 81 182 232 17 72 22
2023/2024972 50 272 32 31 29 195 53 23 12 27 126 122
2024/20251.429 60 75 160 49 209 59 109 101 350 217 40 0
Totale 10.959